Charity investor the Wellcome Trust has launched Syncona Partners, an investment subsidiary managing a £200m ($329m) evergreen fund. Previously announced as Project Sigma by the Trust in March 2012, Syncona will be focused on supporting development of sustainable healthcare businesses. The UK-based fund will invest globally, with investments ranging from between £1m to £20m. Syncona…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.